1-6 of 6
Koen van Besien
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A multicenter phase 2 clinical trial of low-dose subcutaneous decitabine in myelofibrosis

Clinical Trials & Observations
Chenyu Lin, Anand A. Patel, Dezheng Huo, Theodore Karrison, Koen van Besien, John Godwin, Dorie Sher, Howie Weiner, Margaret Green, James L. Wade, III, Rebecca Klisovic, Maria R. Baer, Richard A. Larson, Wendy Stock, Olatoyosi Odenike
Journal: Blood Advances
Blood Adv (2024) 8 (22): 5735–5743.
https://doi.org/10.1182/bloodadvances.2024013215
Published: 2024
Includes: Supplemental data
Journal Articles

Tabelecleucel for EBV + PTLD after allogeneic HCT or SOT in a multicenter expanded access protocol

Clinical Trials & Observations
Sarah Nikiforow, Jennifer S. Whangbo, Ran Reshef, Donald E. Tsai, Nancy Bunin, Rolla Abu-Arja, Kris Michael Mahadeo, Wen-Kai Weng, Koen Van Besien, David Loeb, Sunita Dwivedy Nasta, Eneida R. Nemecek, Weizhi Zhao, Yan Sun, Faith Galderisi, Justin Wahlstrom, Aditi Mehta, Laurence Gamelin, Rajani Dinavahi, Susan Prockop
Journal: Blood Advances
Blood Adv (2024) 8 (12): 3001–3012.
https://doi.org/10.1182/bloodadvances.2023011626
Published: 2024
Includes: Supplemental data
Journal Articles

Adoptive immunotherapy with CB following chemotherapy for patients with refractory myeloid malignancy: chimerism and response

Clinical Trials & Observations
Ok-kyong Chaekal, Andromachi Scaradavou, Emeline Masson Frenet, Maria S. Albano, Melissa Cushing, Pinkal Desai, Ludy Dobrila, Usama Gergis, Danielle Guarneri, Jing-Mei Hsu, Sangmin Lee, Sebastian A. Mayer, Adrienne A. Phillips, Nina Orfali, Ellen K. Ritchie, Gail J. Roboz, Cynthia Romeo, Michael S. Samuel, Tsiporah Shore, Koen van Besien
Journal: Blood Advances
Blood Adv (2020) 4 (20): 5146–5156.
https://doi.org/10.1182/bloodadvances.2020002805
Published: 2020
Includes: Supplemental data
Journal Articles

KIR B donors improve the outcome for AML patients given reduced intensity conditioning and unrelated donor transplantation

Clinical Trials & Observations
Daniel Weisdorf, Sarah Cooley, Tao Wang, Elizabeth Trachtenberg, Cynthia Vierra-Green, Stephen Spellman, Jennifer A. Sees, Ashley Spahn, Jenny Vogel, Todd A. Fehniger, Ann E. Woolfrey, Steven M. Devine, Maureen Ross, Edmund K. Waller, Ronald M. Sobecks, Joseph McGuirk, Betul Oran, Sherif S. Farag, Tsiporah Shore, Koen Van Besien, Steven G. E. Marsh, Lisbeth A. Guethlein, Peter Parham, Jeffrey S. Miller
Journal: Blood Advances
Blood Adv (2020) 4 (4): 740–754.
https://doi.org/10.1182/bloodadvances.2019001053
Published: 2020
Includes: Supplemental data
Journal Articles

Tisagenlecleucel cellular kinetics, dose, and immunogenicity in relation to clinical factors in relapsed/refractory DLBCL

Clinical Trials & Observations
Rakesh Awasthi, Lida Pacaud, Edward Waldron, Constantine S. Tam, Ulrich Jäger, Peter Borchmann, Samantha Jaglowski, Stephen Ronan Foley, Koen van Besien, Nina D. Wagner-Johnston, Marie José Kersten, Stephen J. Schuster, Gilles Salles, Richard T. Maziarz, Özlem Anak, Christopher del Corral, Jufen Chu, Irina Gershgorin, Iulian Pruteanu-Malinici, Abhijit Chakraborty, Karen Thudium Mueller, Edmund K. Waller
Journal: Blood Advances
Blood Adv (2020) 4 (3): 560–572.
https://doi.org/10.1182/bloodadvances.2019000525
Published: 2020
Includes: Supplemental data
Journal Articles

Haploidentical vs haplo-cord transplant in adults under 60 years receiving fludarabine and melphalan conditioning

Clinical Trials & Observations
Koen van Besien, Andrew Artz, Richard E. Champlin, Danielle Guarneri, Michael R. Bishop, Julianne Chen, Usama Gergis, Tsiporah Shore, Hongtao Liu, Gabriela Rondon, Sebastian A. Mayer, Samer A. Srour, Wendy Stock, Stefan O. Ciurea
Journal: Blood Advances
Blood Adv (2019) 3 (12): 1858–1867.
https://doi.org/10.1182/bloodadvances.2019000200
Published: 2019